SCHEMBL7841798

SCHEMBL7841798

CC(C)C[C@@H](C(=O)NN1C(=O)CNC1=O)[C@H](CCCc1ccccc1)C(=O)NOCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.41
MMP13 P45452 1/20 0.41
ECE1 P42892 1/20 0.38
MMP3 P08254 3/20 0.36
MMP8 P22894 3/20 0.35
CTSL P07711 5/20 0.35
CTSK P43235 4/20 0.35
CTSS P25774 3/20 0.35
CTSB P07858 2/20 0.35
MMP2 P08253 2/20 0.34
MMP7 P09237 1/20 0.34
HPGD P15428 1/20 0.34
FCER2 P06734 1/20 0.34
CA5A P35218 1/20 0.34
MMP9 P14780 1/20 0.34
MMP14 P50281 1/20 0.33
APP P05067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7953838 1.00 MMP1 (0.41) MMP1MMP13ECE1MMP3MMP8
SCHEMBL7955728 0.88 MMP1 (0.47) MMP1MMP13MMP3MMP8MMP2
SCHEMBL27449166 0.88 MMP1 (0.47) MMP1MMP13MMP3MMP8MMP2
SCHEMBL7839520 0.88 MMP1 (0.47) MMP1MMP13MMP3MMP8MMP2
SCHEMBL7840632 0.88 MMP1 (0.47) MMP1MMP13MMP3MMP8MMP2
SCHEMBL7957364 0.83 MMP1 (0.39) MMP1MMP13ECE1MMP3CTSL
SCHEMBL7827988 0.83 MMP1 (0.39) MMP1MMP13ECE1MMP3CTSL
SCHEMBL7828548 0.82 CTSL (0.38) MMP1MMP13ECE1MMP3CTSL
SCHEMBL7837319 0.82 CTSL (0.38) MMP1MMP13ECE1MMP3CTSL
SCHEMBL7955158 0.82 MMP1 (0.40) MMP1MMP13ECE1MMP3MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1137640-A1 CYCLIC HYDRAZINE DERIVATIVES AS TNF-ALPHA INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2001-10-04 EP disclosed
US-6281363-B1 ANTIINFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS; AUTOIMMUNE DISORDERS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed
WO-2000035885-A1 CYCLIC HYDRAZINE DERIVATIVES AS TNF-ALPHA INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed